Anocca

About:

Anocca is a drug and immunotherapy developer aiming to uncover the therapeutic potential of T-cell immunity.

Website: https://www.anocca.com/

Top Investors: European Investment Bank, AMF, Mellby Gård AB, Ramsbury Invest AB, Swedbank Robur

Description:

Anocca provides services like biotechnology, immunotherapeutics, drug discovery, drug development, and immunology services. The company does precise and efficient analysis of T-cell biology, which is required to deliver a variety of therapeutics that specifically harness or manipulate T-cell immunity in a number of disease areas, including cancer, assisting the life sciences sector in developing a variety of therapies and vaccination strategies. Anocca was established on October 23, 2014 by Reagan Jarvis in Södertälje, Vasternorrlands Lan.